General MedicationsIONTOPHORESIS, TRANSDERMALGeneric
IONSYS
FENTANYL HYDROCHLORIDE
Standard Dose
EQ 40MCG BASE/ACTIVATION
Max Dose
Refer to approved labeling
Primary Use
Review priority: N/A Marketing status: Discontinued
Summary
Approval overview IONSYS is listed in Drugs@FDA under application 021338 (NDA).
Review priority: N/A Marketing status: Discontinued Active ingredient FENTANYL HYDROCHLORIDE Form and strength SYSTEM;IONTOPHORESIS, TRANSDERMAL - EQ 40MCG BASE/ACTIVATION Sponsor THE MEDICINES CO Submission history Latest submission status date: 2018-10-03 00:00:00.
Structured Monograph
Clinical summary
Approval overview IONSYS is listed in Drugs@FDA under application 021338 (NDA). Review priority: N/A Marketing status: Discontinued Active ingredient FENTANYL HYDROCHLORIDE Form and strength SYSTEM;IONTOPHORESIS, TRANSDERMAL - EQ 40MCG BASE/ACTIVATION Sponsor THE MEDICINES CO Submission history Latest submission status date: 2018-10-03 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: N/A
Interaction Notes
- No interaction notes stored yet.